Amanta Healthcare Share Price
194.03+3.80 (+2.00%)
+36.88% past 1 Year
Amanta Healthcare is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal
Corporate filings & documents
Announcements
Newspaper publication
19 hours agoNewspaper publication
19 hours agoAmanta Healthcare Limited Announces Commissioning of New SteriPort Line
1 day agoAmanta Healthcare Limited Announces Commissioning of New SteriPort Line
1 day agoIntimation - Regulation 36(1)(b) of the SEBI Listing Regulations
1 week agoIntimation - Regulation 36(1)(b) of the SEBI Listing Regulations
1 week agoNewspaper Advertisement for dispatch of Annual Report of the 31st Annual General Meeting and e-voting information
1 week agoNewspaper Advertisement for dispatch of Annual Report of the 31st Annual General Meeting and e-voting information
1 week agoAnnual Report for Financial Year 2025-26
1 week agoAnnual Report for Financial Year 2025-26
1 week agoNotice of 31st Annual General Meeting and Annual Report for F.Y. 2025-26
1 week agoNotice of 31st Annual General Meeting and Annual Report for F.Y. 2025-26
1 week agoAnnual Report for Financial Year 2025-26
1 week agoAnnual Report for Financial Year 2025-26
1 week agoSubmission of Newspaper clippings - Advertisement addressed to the Shareholders for Annual General Meeting
3 weeks agoSubmission of Newspaper clippings - Advertisement addressed to the Shareholders for Annual General Meeting
3 weeks agoEarnings Call Transcript for quarter ended June 30 2026
3 weeks agoEarnings Call Transcript for quarter ended June 30 2026
3 weeks agoMonitoring Agency Report for the quarter ended June 30 2026
3 weeks agoMonitoring Agency Report for the quarter ended June 30 2026
3 weeks agoPublication of Financial Results in Newspapers
3 weeks agoPublication of Financial Results in Newspapers
3 weeks agoSubmission of Audio Recording of Post Results Conference Call held on August 6 2026
4 weeks agoSubmission of Audio Recording of Post Results Conference Call held on August 6 2026
4 weeks agoAnnouncement under Reg 30- Press Release
4 weeks agoAnnouncement under Reg 30- Press Release
4 weeks agoStatement of Deviation or Variation in utilization of funds if any
4 weeks agoStatement of Deviation or Variation in utilization of funds if any
4 weeks agoInvestor Presentation
4 weeks agoInvestor Presentation
4 weeks agoTo approve unaudited Financial Results for the Quarter ended 30th June 2026
4 weeks agoTo approve unaudited Financial Results for the Quarter ended 30th June 2026
4 weeks agoTo approve unaudited Financial Results for quarter ended 30th June 2026
4 weeks agoTo approve unaudited Financial Results for quarter ended 30th June 2026
4 weeks agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 for change in Senior Management Personnel of the Company
4 weeks agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 for change in Senior Management Personnel of the Company
4 weeks agoIntimation of Schedule of the Earnings Conference Call for Q1 ended June 30 2026
1 month agoIntimation of Schedule of the Earnings Conference Call for Q1 ended June 30 2026
1 month agoAmanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Considering And Approving the Un-Audited Financial Results for the quarter ended June 30 2026
1 month agoAmanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Considering And Approving the Un-Audited Financial Results for the quarter ended June 30 2026
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
1 month agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1 month agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1 month agoIntimation of Schedule of Investor Meet
1 month agoIntimation of Schedule of Investor Meet
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhavesh G Patel
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhavesh G Patel
2 months agoSubmission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 - Off Market transfer of equity shares
2 months agoSubmission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 - Off Market transfer of equity shares
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
8th Floor, Shaligram Corporates C. J. Marg Ambli Ahmedabad Gujarat PIN: 380058 Tel No: 079-67777600 Fax No: 079-30017600 Email: [email protected] Internet: www.amanta.co.in
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Bhavesh Patel, Chairman & Managing Director
Bhavesh Patel, Chairman & Managing Director
Nitin Jain, Non Executive Independent Director
Anjali Choksi, Non Executive Independent Director
Kshitij Patel, Non Executive Independent Director
Nimesh Patel, Non Executive Director
Pratik Gandhi, Non Executive Director
Nikhita Dinodia, Company Secretary & Compliance Officer
Details
BSE 544502
NSE AMANTA
ISIN INE084K01015